We are live on ! Find out more
Jane Street

Jane Street Portfolio holdings

AUM $777B
1-Year Est. Return 61.18%
 

Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.

This Fund
S&P 500
This Quarter Est. Return
+7.07%
1 Year Est. Return
+61.18%
3 Year Est. Return
+147.64%
5 Year Est. Return
+157.48%
10 Year Est. Return
+594.2%
AUM
$7.86B
AUM Growth
-$1.18B
Cap. Flow
-$1.51B
Cap. Flow %
-19.2%
Top 10 Hldgs %
19.15%
Holding
3,648
New
1,015
Increased
681
Reduced
769
Closed
1,159

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$132M
2
AAPL icon
Apple
AAPL
+$82.1M
3
BP icon
BP
BP
+$66M
4
DEO icon
Diageo
DEO
+$54.2M
5
IWM icon
iShares Russell 2000 ETF
IWM
+$49.9M

Sector Composition

Rank Sector Weight
1 Energy 4.3%
2 Technology 4.3%
3 Communication Services 4.24%
4 Healthcare 4.07%
5 Consumer Discretionary 2.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GPT
2401
DELISTED
Gramercy Property Trust
GPT
$70K ﹤0.01%
3,859
-1,128
-23% -$18.8K
LCTX icon
2402
Lineage Cell Therapeutics
LCTX
$264M
$69K ﹤0.01%
+28,036
New +$63.3K
ARTX
2403
DELISTED
Arotech Corporation
ARTX
$69K ﹤0.01%
15,575
-252,032
-94% -$1.07M
OHAI
2404
DELISTED
OHA Investment Corporation
OHAI
$67K ﹤0.01%
+10,748
New +$69.9K
FCEL icon
2405
FuelCell Energy
FCEL
$1.45B
$66K ﹤0.01%
6
+1
+20% +$9.9K
NEON icon
2406
Neonode
NEON
$12.6M
$66K ﹤0.01%
+2,101
New +$91.2K
RIOM
2407
DELISTED
RIO ALTO MNG LTD NEW COM SHS (CANADA)
RIOM
$66K ﹤0.01%
28,400
-119,146
-81% -$234K
TEUM
2408
DELISTED
Pareteum Corporation
TEUM
$64K ﹤0.01%
2,689
-1,137
-30% -$27.7K
PRMW
2409
DELISTED
Primo Water Corporation
PRMW
$64K ﹤0.01%
+13,447
New +$57.7K
GSS
2410
DELISTED
Golden Star Resources Ltd.
GSS
$62K ﹤0.01%
20,861
+5,441
+35% +$15.6K
UTSI icon
2411
UTStarcom
UTSI
$22M
$61K ﹤0.01%
5,180
-1,969
-28% -$22.1K
VPCO
2412
DELISTED
VAPOR CORP DEL COM STK
VPCO
$61K ﹤0.01%
+2,476
New +$65.9K
CBAT icon
2413
CBAK Energy Technology Ltd
CBAT
$43.1M
$59K ﹤0.01%
25,223
-7,831
-24% -$19.8K
ACFN
2414
DELISTED
Acorn Energy Inc
ACFN
$59K ﹤0.01%
25,031
+10,078
+67% +$23.1K
TC
2415
DELISTED
Thompson Creek Metals Company Inc. Ordinary Shares (Canada)
TC
$57K ﹤0.01%
+19,325
New +$53.2K
SCLN
2416
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
$56K ﹤0.01%
+10,563
New +$51.4K
ECTE
2417
DELISTED
ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE
$56K ﹤0.01%
+24,744
New +$61.5K
PLX icon
2418
Protalix BioTherapeutics
PLX
$183M
$53K ﹤0.01%
1,443
+367
+34% +$14.8K
SUMR
2419
DELISTED
Summer Infant, Inc.
SUMR
$52K ﹤0.01%
+2,025
New +$45.8K
MEET
2420
DELISTED
The Meet Group, Inc. Common Stock
MEET
$52K ﹤0.01%
19,207
+6,141
+47% +$15.3K
NVAX icon
2421
Novavax
NVAX
$1.21B
$51K ﹤0.01%
+553
New +$48.6K
TCRT icon
2422
Alaunos Therapeutics
TCRT
$4.64M
$51K ﹤0.01%
+84
New +$46.8K
MMAT
2423
DELISTED
Meta Materials Inc. Common Stock
MMAT
$50K ﹤0.01%
+61
New +$54.3K
REDF
2424
DELISTED
REDIFF.COM INDIA LTD ADS
REDF
$50K ﹤0.01%
+16,491
New +$40.7K
MTL
2425
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
$50K ﹤0.01%
11,482
-13,312
-54% -$54K

Similar funds

Jane Street's Q2 2014 Portfolio in Review

As of Q2 2014, Jane Street held 3,648 positions worth $7.86B, down 13% from $9.04B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Jane Street withdrew a net $1.51B in Q2 2014, closing 1,159 positions and reducing 769 holdings. Its most notable exit was State Street SPDR S&P MIDCAP 400 ETF Trust, an estimated $152M position sold in full.

By sector, the portfolio is most concentrated in Energy at 4.3% of assets, up from 3.2% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Jane Street opened a new position in Diageo worth $54.7M.

  • Jane Street's largest Q2 2014 buy was Diageo: 430,064 shares worth $54.7M.
  • Jane Street added most to AstraZeneca in Q2 2014, an estimated $132M increase.
  • Jane Street's biggest Q2 2014 reduction was WisdomTree Japan Hedged Equity Fund, cutting an estimated $157M.
  • Jane Street fully exited State Street SPDR S&P MIDCAP 400 ETF Trust in Q2 2014, selling an estimated $152M.
  • Jane Street's ten largest holdings make up 19% of its $7.86B portfolio in Q2 2014.
  • Jane Street opened 1,015 new positions and closed 1,159 in Q2 2014.
  • Jane Street's portfolio value fell 13% quarter-over-quarter to $7.86B.

Based on Jane Street's 13F filing for Q2 2014, filed 14 Aug 2014.